single-dr.php

JDR Vol.17 No.1 pp. 21-30
(2022)
doi: 10.20965/jdr.2022.p0021

Note:

Questionnaire Survey on COVID-19 Vaccination at Okayama University in Japan: Factors Promoting Vaccination Among Young Adults

Chigusa Higuchi*,†, Naomi Matsumoto**, Yoshiaki Iwasaki*, Takashi Yorifuji**, Junichiro Yamazaki***, Yasutomo Nasu***, and Hirofumi Makino***

*Okayama University Health Service Center
2-1-1 Tsushima Naka, Kita-ku, Okayama, Okayama 700-8530, Japan

Corresponding author

**Department of Epidemiology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan

***Okayama University, Okayama, Japan

Received:
October 4, 2021
Accepted:
December 3, 2021
Published:
January 30, 2022
Keywords:
COVID-19 vaccine, vaccine hesitancy, young adults, information literacy, satisfaction
Abstract

COVID-19 has been prevalent worldwide since 2019. Increasing COVID-19 vaccination coverage is an important measure to combat the disease. An online survey was conducted with university students and personnel who were vaccinated against COVID-19 at a mass vaccination event to examine the factors promoting vaccination among young adults. The online survey was conducted with persons vaccinated at Okayama University from June 5 to September 27, 2021. Although the number of those who had fever >37.5°C increased after the second vaccination compared to the first, the vaccinated persons got more satisfied after the second shot.

Cite this article as:
Chigusa Higuchi, Naomi Matsumoto, Yoshiaki Iwasaki, Takashi Yorifuji, Junichiro Yamazaki, Yasutomo Nasu, and Hirofumi Makino, “Questionnaire Survey on COVID-19 Vaccination at Okayama University in Japan: Factors Promoting Vaccination Among Young Adults,” J. Disaster Res., Vol.17, No.1, pp. 21-30, 2022.
Data files:
References
  1. [1] World Health Organization (WHO), “Coronavirus (COVID-19) Dashboard 2021,” https://covid19.who.int [accessed September 23, 2021]
  2. [2] S. Shinoda, “Epidemiology of the novel coronavirus disease 2019 (COVID-19) and several remarkable pandemics,” J. Disaster Res., Vol.16, pp. 97-109, doi: 10.20965/jdr.2021.p0097, 2021.
  3. [3] Japan Ministry of Health, Labour and Welfare, “Outbreaks in Japan, etc.,” https://www.mhlw.go.jp/stf/covid-19/kokunainohasseijoukyou.html (in Japanese) [accessed September 23, 2021]
  4. [4] N. Nakanishi and Y. Iijima, “The novel coronavirus pandemic and the state of the epidemic in Kobe, Japan,” J. Disaster Res., Vol.16, pp. 84-87, doi: 10.20965/jdr.2021.p0084, 2021.
  5. [5] L. R. Baden, H. M. El Sahly, B. Essink et al., “Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine,” N. Engl. J. Med., Vol.384, pp. 403-416, 2021.
  6. [6] F. P. Polack, S. J. Thomas, N. Kitchin et al., “Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine,” N. Engl. J. Med., Vol.383, pp. 2603-2615, 2020.
  7. [7] W. Sadaqat, S. Habib, A. Tauseef, S. Akhtar, M. Hayat, S. A. Shujaat, and A. Mahmood, “Determination of COVID-19 vaccine hesitancy among university students,” Cureus, Vol.13, No.8, doi: 10.7759/cureus.17283, 2021.
  8. [8] R. Okubo, T. Yoshioka, S. Ohfuji, T. Matsuo, and T. Tabuchi, “COVID-19 vaccine hesitancy and its associated factors in Japan,” Vaccines, Vol.9, doi: 10.3390/vaccines9060662, 2021.
  9. [9] T. Sontayasara, S. Jariyapongpaiboon, A. Promjun, N. Seelpipat, K. Saengtabtim, J. Tang, and N. Leelawat, “Twitter sentiment analysis of Bangkok tourism during COVID-19 pandemic using support vector machine algorithm,” J. Disaster Res., Vol.16, pp. 24-30, doi: 10.20965/jdr.2021.p0024, 2021.
  10. [10] Okayama Prefecture, “Provision of information on new coronavirus vaccination,” https://www.pref.okayama.jp/page/697878.html (in Japanese) [accessed September 23, 2021]
  11. [11] Okayama City, “COVID-19 Vaccine General Vaccination,” https://www.city.okayama.jp/0000030645.html (in Japanese) [accessed September 23, 2021]
  12. [12] J. Roozenbeek, C. R. Schneider, S. Dryhurst, J. Kerr, A. L. J. Freeman, G. Recchia, A. M. van der Bles, and S. van der Linden, “Susceptibility to misinformation about COVID-19 around the world,” R. Soc. Open Sci., Vol.7, doi: 10.1098/rsos.201199, 2020.
  13. [13] N. Puri, E. A. Coomes, H. Haghbayan, and K. Gunaratne, “Social media and vaccine hesitancy: new updates for the era of COVID-19 and globalized infectious diseases,” Hum. Vaccin. Immunother., Vol.16, pp. 2586-2593, 2020.
  14. [14] D. A. DeWalt, N. D. Berkman, S. Sheridan, K. N. Lohr, and M. P. Pignone, “Literacy and health outcomes: A systematic review of the literature,” J. Gen. Intern. Med., Vol.19, pp. 1228-1239, 2004.
  15. [15] K. Sorensen, S. Van den Broucke, J. Fullam, G. Doyle, J. Pelikan, Z. Slonska et al., “Health literacy and public health: A systematic review and integration of definitions and models,” BMC Public Health, Vol.12, Article No.80, 2012.
  16. [16] J. Jung, H. Sung, and S.-H. Kim, “Covid-19 breakthrough infections in vaccinated health care workers,” N. Engl. J Med., Vol.385, pp. 1629-1630, 2021.
  17. [17] M. Klompas, “Understanding breakthrough infections following mRNA SARS-CoV-2 vaccination,” JAMA, Vol.326, pp. 2018-2020, 2021.
  18. [18] S. Stokes, K. Shek, and M. Hung, “Breakthroughs, boosters, and beyond: a practical primer on current challenges with COVID-19,” Emerg. Med. Pract., Vol.23, pp. 1-22, 2021.
  19. [19] J. L. Bernal, N. Andrews, C. Gower et al., “Effectiveness of Covid-19 vaccines against the B.1.617.2 (Delta) variant,” N. Engl. J. Med., Vol.385, pp. 585-594, 2021.
  20. [20] Japan Ministry of Health, Labour and Welfare, “Notice of COVID-19 vaccination,” https://www.mhlw.go.jp/content/000804437.pdf (in Japanese) [accessed September 23, 2021]
  21. [21] Okayama University, “Interim report on Takeda/Medrona post-vaccination adverse reactions to COVID-19 vaccine,” https://www.okayama-u.ac.jp/tp/release/release_id868.html (in Japanese) [accessed November 20, 2021]
  22. [22] Okayama University, “Final report on Takeda/Medrona post-vaccination adverse reactions to COVID-19 vaccine,” https://www.okayama-u.ac.jp/tp/release/release_id875.html (in Japanese) [accessed November 20, 2021]

*This site is desgined based on HTML5 and CSS3 for modern browsers, e.g. Chrome, Firefox, Safari, Edge, Opera.

Last updated on May. 20, 2022